Kusuri no Madoguchi is acquiring Mediwab to expand into the healthcare institution market, enhancing its technology solutions portfolio.
Target Information
Kusuri no Madoguchi Co., Ltd. operates a pharmacy search and reservation platform and is involved in system development for pharmacies. Historically focused on serving the pharmacy market, the company is expanding its reach by acquiring Mediwab, a Tokyo-based firm that operates a medical appointment reservation website and sells automated payment machines. This acquisition marks Kusuri no Madoguchi's formal entry into the healthcare institution market, allowing it to diversify its portfolio and enhance its service offerings.
Mediwab reported sales of 965 million yen and an operating profit of 97 million yen for the fiscal year ending March 2025. The company has a net asset value of 131 million yen, indicating a solid financial foundation as it prepares to integrate with Kusuri no Madoguchi.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Japan
The Japanese healthcare market is one of the largest in the world, characterized by a well-established framework that combines public and private providers to deliver comprehensive health services. The ongoing digital transformation in the sector has accelerated the adoption of
Similar Deals
くすりの窓口
invested in
メディ・ウェブ
in 2026
in a Other deal
Disclosed details
Revenue: $10M
EBIT: $1M